Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells

Published:2009-02-09 Issue:12 Volume:28 Page:1518-1528
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Prasad A,Park I-W,Allen H,Zhang X,Reddy M V R,Boominathan R,Reddy E P,Groopman J E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2008502.pdf

Reference41 articles.

1. Adams JM, Cory S . (2007). Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19: 488–496.

2. Alam A, Cohen LY, Aouad S, Sekaly RP . (1999). Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 190: 1879–1890.

3. Aoki M, Jiang H, Vogt PK . (2004). Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA 101: 13613–13617.

4. Armengol G, Rojo F, Castellvi J, Iglesias C, Cuatrecasas M, Pons B et al. (2007). 4E-binding protein 1: a key molecular ‘funnel factor’ in human cancer with clinical implications. Cancer Res 67: 7551–7555.

5. Bertoni F, Ponzoni M . (2007). The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 39: 1747–1753.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From lab to clinic: The discovery and optimization journey of PI3K inhibitors;European Journal of Medicinal Chemistry;2024-11

2. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy;JCI Insight;2024-05-30

3. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy;2023-07-28

4. In the Pipeline: Emerging Therapy for MDS and MDS/MPN;Pathogenesis and Treatment of Leukemia;2023

5. Polo-like kinase 1 (PLK1) signaling in cancer and beyond;Biochemical Pharmacology;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3